HomeCompareBAX vs MRO

BAX vs MRO: Dividend Comparison 2026

BAX yields 2.28% · MRO yields 1.54%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRO wins by $21.89M in total portfolio value
10 years
BAX
BAX
● Live price
2.28%
Share price
$15.80
Annual div
$0.36
5Y div CAGR
-27%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$10.26
Full BAX calculator →
MRO
MRO
● Live price
1.54%
Share price
$28.55
Annual div
$0.44
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.91M
Annual income
$19,482,927.42
Full MRO calculator →

Portfolio growth — BAX vs MRO

📍 MRO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBAXMRO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BAX + MRO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BAX pays
MRO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BAX
Annual income on $10K today (after 15% tax)
$193.67/yr
After 10yr DRIP, annual income (after tax)
$8.72/yr
MRO
Annual income on $10K today (after 15% tax)
$131.00/yr
After 10yr DRIP, annual income (after tax)
$16,560,488.31/yr
At 15% tax rate, MRO beats the other by $16,560,479.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BAX + MRO for your $10,000?

BAX: 50%MRO: 50%
100% MRO50/50100% BAX
Portfolio after 10yr
$10.97M
Annual income
$9,741,468.84/yr
Blended yield
88.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRO right now

BAX
Analyst Ratings
15
Buy
20
Hold
1
Sell
Consensus: Hold
Price Target
$19.75
+25.0% upside vs current
Range: $15.00 — $25.00
Altman Z
2.1
Piotroski
5/9
MRO
Analyst Ratings
1
Strong
23
Buy
28
Hold
1
Sell
Consensus: Hold
Price Target
$29.00
+1.6% upside vs current
Range: $14.00 — $48.00
Altman Z
2.7
Piotroski
9/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BAX buys
0
MRO buys
0
No recent congressional trades found for BAX or MRO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBAXMRO
Forward yield2.28%1.54%
Annual dividend / share$0.36$0.44
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-27%100%
Portfolio after 10y$20.6K$21.91M
Annual income after 10y$10.26$19,482,927.42
Total dividends collected$602.00$21.70M
Payment frequencyquarterlyquarterly
SectorHealthcareEnergy
Analyst consensusHoldHold
Analyst price target$19.75$29.00

Year-by-year: BAX vs MRO ($10,000, DRIP)

YearBAX PortfolioBAX Income/yrMRO PortfolioMRO Income/yrGap
1← crossover$10,866$166.33$11,008$308.23$142.00MRO
2$11,750$123.31$12,413$634.22$663.00MRO
3$12,664$90.97$14,619$1,336.74$2.0KMRO
4$13,617$66.89$18,585$2,942.55$5.0KMRO
5$14,619$49.07$26,878$6,992.19$12.3KMRO
6$15,679$35.94$47,661$18,901.61$32.0KMRO
7$16,802$26.30$113,646$62,649.00$96.8KMRO
8$17,998$19.23$400,826$279,224.78$382.8KMRO
9$19,272$14.05$2,269,665$1,840,780.90$2.25MMRO
10$20,631$10.26$21,911,469$19,482,927.42$21.89MMRO

BAX vs MRO: Complete Analysis 2026

BAXHealthcare

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Full BAX Calculator →

MROEnergy

Marathon Oil Corporation operates as an independent exploration and production company in the United States and internationally. The company engages in the exploration, production, and marketing of crude oil and condensate, natural gas liquids, and natural gas; and the production and marketing of products manufactured from natural gas, such as liquefied natural gas and methanol. It also owns and operates 32 central gathering and treating facilities; and the Sugarloaf gathering system, a 42-mile natural gas pipeline through Karnes and Atascosa Counties. The company was formerly known as USX Corporation and changed its name to Marathon Oil Corporation in December 2001. Marathon Oil Corporation was founded in 1887 and is headquartered in Houston, Texas.

Full MRO Calculator →
📬

Get this BAX vs MRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BAX vs SCHDBAX vs JEPIBAX vs OBAX vs KOBAX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.